Aptamer-Based Metal Binding for Lead Protection and Biomining
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for treating heavy metal toxicity, such as lead poisoning, are ineffective at preventing absorption and do not address low-level exposures, leading to cumulative and irreversible health effects, while current mining practices for rare earth elements are environmentally damaging.
Innovation Solution
Utilizing aptamers, specifically DNA or RNA strands with high affinity for toxic metals, to bind and expel them through normal physiological processes, and employing these strands for biomining to recover rare earth elements.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional chelation therapy is used to treat heavy metal toxicity, then high-level lead poisoning can be treated, but low-level exposures are not addressed and cumulative effects occur
Solution Approach 1:
The aptamer is introduced into the body before lead exposure occurs, binding to lead ions in the gastrointestinal tract and preventing absorption. This preliminary action continues throughout the exposure period, addressing low-level cumulative effects rather than treating only high-level poisoning after it occurs.
Solution Approach 2:
The aptamer provides continuous protection against lead absorption throughout the entire exposure period. By maintaining constant binding capacity in the gastrointestinal tract, it continuously prevents lead uptake regardless of exposure level, eliminating the need for intermittent chelation therapy.
2Productivity
If traditional mining methods are used to extract rare earth elements, then REEs can be recovered, but environmental degradation and toxicity occur
Solution Approach 1:
The aptamer-based system performs the extraction function autonomously within the biological organism. The aptamer naturally binds to rare earth elements in the environment, and the organism's normal physiological processes handle the extraction and elimination, eliminating the need for harsh chemical mining operations.
Solution Approach 2:
The system converts the organism's natural metabolic processes into a beneficial extraction mechanism. By introducing the aptamer, the organism's normal cellular functions are harnessed to perform rare earth element recovery, transforming what would be harmful industrial mining into a biocompatible process.
3Quantity of substance
If protein-based chelators are used to bind metals, then metal binding capacity is achieved, but metabolic cost increases due to protein production requirements
Solution Approach 1:
The patent uses nucleic acid aptamers as a molecular copy or analogue of protein chelators. These aptamers perform the same metal binding function as proteins but are synthesized through replication of the nucleic acid sequence rather than protein translation, significantly reducing the metabolic energy required for production.
Solution Approach 2:
The invention changes the molecular parameter of the chelator from protein-based to nucleic acid-based. This parameter change fundamentally alters the synthesis pathway from ribosomal protein production to nucleic acid replication, reducing the metabolic cost while maintaining metal binding capacity through the aptamer's high affinity for target metals.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Aptamers effectively prevent heavy metal absorption and eliminate toxic metals, reducing disease burden and environmental impact, while providing a sustainable method for rare earth element extraction.
Implementation Method 1
Aptamers are recognized in biology and biotechnology for use in binding to specific target molecules such proteins, peptides, or small molecules, with high affinity and specificity
Implementation Method 2
A nucleic acid strand is generated to include the binding aptamer, and is introduced into a cellular organism for binding with the target substance
Data Source
AI summary
Aptamers are recognized in biology and biotechnology for use in binding to specific target molecules such proteins, peptides, or small molecules, with high affinity and specificity. Traditional use has focused on antibodies and related cell chemistry. However, these short nucleic acid strands, typically DNA or RNA with other chemical base modifications, may be used for gathering and collection of various molecular substances. A method of biomining an earthborn substance binds and sequesters rare earth elements by identifying an earthborn, target substance sought for mining, and determining a binding aptamer having an affinity for the target substance. A nucleic acid strand is generated to include the binding aptamer, and is introduced into a cellular organism for binding with the target substance. Following binding of the nucleic acid strand with the target substance, separation of target substance occurs for collection of the target substance.